Key points are not available for this paper at this time.
The purpose of this study was to evaluate the desired and undesired effects of relapse-preventive lithium treatment given routinely to manic-melancholic patients who had accepted the necessity of a strict tablet regime. The evaluation was based upon case record data and various rating scales, and 76 patients took part in the investigation. Our results showed that in 24% of the patients treatment was discontinued. This was due to side effects in 16% and to insufficient effect in 8% of the cases. The suicide risk was not eliminated, and 29% of the patients were receiving additional antidepressive or antimanic treatment at the test day. On the other hand, 78% of the patients rated the relapse-preventive lithium effect as moderate to excellent. Indirect evidence was obtained in support of a stabilizing effect of lithium on the emotional control in bipolar patients. The most frequent complaints during lithium treatment were tremor and increased thirst.
Bech et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: